Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

ClinicalTrials.gov ID: NCT00952380

Public ClinicalTrials.gov record NCT00952380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A THREE MONTH PROSPECTIVE OPEN LABEL STUDY OF THERAPY WITH FRAGMIN(REGISTERED) (DALTEPARIN SODIUM INJECTION) IN CHILDREN WITH VENOUS THROMBOEMBOLISM WITH OR WITHOUT MALIGNANCIES

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Three month treatment of acute VTE with Fragmin in pediatric cancer patients

Study identification

NCT ID
NCT00952380
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
38 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Up to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2009
Primary completion
Feb 28, 2018
Completion
Feb 28, 2018
Last update posted
Apr 15, 2019

2009 – 2018

United States locations

U.S. sites
17
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Children's Hospital Colorado Aurora Colorado 80045
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007
Nemours Children's Clinic Jacksonville Florida 32207
Wolfson Children's Hospital Jacksonville Florida 32207
Investigational Drug Service Tampa General Hospital Tampa Florida 33606
Tampa General Hospital Center of Research Excellence Tampa Florida 33606
Tampa General Hospital Tampa Florida 33606
University of South Florida Tampa Florida 33606
St. Joseph's Children's Hospital of Tampa Tampa Florida 33607
Children's Hospital of Michigan Detroit Michigan 48201
Children's Mercy Hospitals and Clinics Kansas City Missouri 64108
St. Jude Children's Research Hospital Memphis Tennessee 38105
El Paso Children's Hospital El Paso Texas 79905
Texas Tech University Health Sciences Center El Paso El Paso Texas 79905
Texas Children's Cancer and Hematology Centers Houston Texas 77030
Texas Children's Hospital Investigational Pharmacy Services Houston Texas 77030
Texas Children's Hospital Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00952380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2019 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00952380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →